BIO and Kentucky Life Sciences Council voiced support for Kentucky Senate Bill 134, legislation that properly preserves patient and physician access to accurate prescription information, while promoting a competitive market for complex biologic medicines. Legislation gives pharmacists ability to substitute lower cost interchangeable biologic medicines while safeguarding primacy of physician-patient relationship and maintaining communication between patients and their treatment teams.